Drug intelligence / Profile preview

Brumeton

Development stage
Unknown
Lead developer
Bruschettini
Modality
Small Molecules
Administration
Ophthalmic, Otic
01

Overview

Brumeton (also known as Brumeton Colloidale) is a combination ophthalmic and otic solution containing the corticosteroid betamethasone (as betamethasone sodium phosphate) and the sulfonamide antibacterial sulfacetamide sodium. Developed by Bruschettini, it is indicated for the local treatment and prophylaxis of superficial ocular inflammations and infections (such as blepharitis, conjunctivitis, and keratitis) as well as otitis externa and media. Betamethasone acts as an anti-inflammatory agent by binding to and activating the glucocorticoid receptor, while sulfacetamide sodium provides bacteriostatic activity by inhibiting bacterial dihydropteroate synthase, thereby blocking folate synthesis.

Brand names
BrumetonBrumeton ColloidaleBrumeton Colloidale SCelestone-S
Other names
betamethasone + sulfacetamidebetamethasone + sulfacetamide sodiumbetamethasone sodium phosphate + sulfacetamide sodium
02

Targets

DHPS (Dihydropteroate synthase)GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on Brumeton.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brumeton.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call